申请人:Pfizer Inc
公开号:US06218397B1
公开(公告)日:2001-04-17
A compound of the formula:
and the pharmaceutically acceptable acid addition salts thereof, wherein
A is NR1R2, CR1R2R11, or C(═CR1R12)R2, NHCR1R2R11, OCR1R2R11, SCR1R2R11, NHNR1R2, CR2R11NHR1, CR2R11OR1, CR2R11SR1 or C(O)R2;
wherein the rest of the variables are herein below defined, used for inflammatory disorders.
以下为该化合物的中文翻译及其药用酸盐:
该化合物的化学式为:其中A为NR1R2、CR1R2R11、或C(═CR1R12)R2、NHCR1R2R11、OCR1R2R11、SCR1R2R11、NHNR1R2、CR2R11NHR1、CR2R11OR1、CR2R11SR1或C(O)R2;其中其余变量定义如下,用于治疗炎症性疾病。